University Hospital of Schleswig-Holstein
Welcome,         Profile    Billing    Logout  
 1 Trial 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cakiroglu, Figen
NCT06734234: A Study to Evaluate the Safety, Tolerability, and Effects on Blood and Urine Markers of Single Ascending Dose of GSK4771261 in Healthy Participants and Participants With Autosomal Dominant Polycystic Kidney Disease

Recruiting
1
84
Europe
GSK4771261, Placebo matching GSK4771261
GlaxoSmithKline
Kidney Disease
07/26
08/26
AD(H)PKD, NCT02497521: The German ADPKD Tolvaptan Treatment Registry

Recruiting
N/A
2000
Europe
University of Cologne
ADPKD (Autosomal Dominant Polycystic Kidney Disease)
11/25
12/27
Schmitt, Roland
EMPA-PKD, NCT06391450: Study of Empagliflozin in Patients with Autosomal Dominant Polycystic Kidney Disease

Recruiting
4
44
Europe
Empagliflozin 10 MG, Placebo
Hannover Medical School, Boehringer Ingelheim
Autosomal Dominant Polycystic Kidney
05/27
05/27
AD(H)PKD, NCT02497521: The German ADPKD Tolvaptan Treatment Registry

Recruiting
N/A
2000
Europe
University of Cologne
ADPKD (Autosomal Dominant Polycystic Kidney Disease)
11/25
12/27

Download Options